Breaking News Instant updates and real-time market news.

ACB

Aurora Cannabis

$10.02 /

-0.18 (-1.76%)

, CGC

Canopy Growth

$30.30 /

-0.31 (-1.01%)

15:42
01/08/21
01/08
15:42
01/08/21
15:42

Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says

Just as it appeared that New Jersey Governor Phil Murphy's office and the state's legislature had reached a deal that would legalize marijuana in the Garden State, opposition from lawmakers has derailed the effort, NJ.com's Amanda Hoover reports. State Senator Nicholas Scutari, a Democrat who sponsored a "cleanup bill" to address the governor's call to add penalties for underage use of cannabis, said that the measure will not be put up to a vote in the full Senate on Monday after other senators objected to it, Hoover says. Murphy has declined to sign bills passed last month to legalize and decriminalize marijuana without changes that enact penalties for those under 21 caught with the substance, the author notes. Publicly traded companies in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE). Reference Link

ACB

Aurora Cannabis

$10.02 /

-0.18 (-1.76%)

CGC

Canopy Growth

$30.30 /

-0.31 (-1.01%)

IGC

India Globalization Capital

$1.79 /

-0.09 (-4.79%)

CANN

General Cannabis

$0.00 /

+ (+0.00%)

ZYNE

Zynerba

$3.45 /

-0.04 (-1.15%)

CRON

Cronos Group

$9.02 /

+0.215 (+2.44%)

TLRY

Tilray

$11.33 /

-0.02 (-0.18%)

CVSI

CV Sciences

$0.00 /

+ (+0.00%)

CNTTF

CannTrust Holdings

$0.00 /

+ (+0.00%)

APHA

Aphria

$8.53 /

-0.055 (-0.64%)

TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

  • 11

    Jan

  • 11

    Jan

  • 14

    Jan

  • 15

    Mar

  • 11

    Nov

ACB Aurora Cannabis
$10.02 /

-0.18 (-1.76%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
CGC Canopy Growth
$30.30 /

-0.31 (-1.01%)

01/05/21 Cantor Fitzgerald
Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
12/28/20 JPMorgan
Constellation Brands price target raised to $248 from $218 at JPMorgan
12/24/20 Raymond James
Raymond James says Village Farms situated well for cannabis sector consolidation
IGC India Globalization Capital
$1.79 /

-0.09 (-4.79%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
CANN General Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$3.45 /

-0.04 (-1.15%)

12/21/20 H.C. Wainwright
Zynerba price target lowered to $9 from $12 at H.C. Wainwright
07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
CRON Cronos Group
$9.02 /

+0.215 (+2.44%)

11/16/20 Jefferies
Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
TLRY Tilray
$11.33 /

-0.02 (-0.18%)

12/17/20 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
12/17/20 Stifel
Tilray upgraded to Hold from Sell at Stifel
12/17/20 Stifel
Aphria downgraded to Hold from Buy at Stifel
CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
CNTTF CannTrust Holdings
$0.00 /

+ (+0.00%)

APHA Aphria
$8.53 /

-0.055 (-0.64%)

12/17/20 CIBC
Aphria price target raised to C$12.50 from C$9 at CIBC
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

11/18/20 Craig-Hallum
Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
11/17/20 Alliance Global Partners
Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global

TODAY'S FREE FLY STORIES

Recommendations
Ulta Beauty price target raised to $365 from $335 at UBS » 07:35
03/01/21
03/01
07:35
03/01/21
07:35
ULTA

Ulta Beauty

$322.40 /

-5.08 (-1.55%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$322.40 /

-5.08 (-1.55%)

ULTA Ulta Beauty
$322.40 /

-5.08 (-1.55%)

02/17/21 Oppenheimer
Ulta Beauty price target raised to $360 from $305 at Oppenheimer
01/27/21 Citi
Ulta Beauty downgraded to Neutral from Buy at Citi
01/21/21 Wells Fargo
Ulta Beauty price target raised to $330 from $320 at Wells Fargo
01/11/21 Cleveland Research
Ulta Beauty Q4-to-date comps appear ahead of consensus, says Cleveland Research
ULTA Ulta Beauty
$322.40 /

-5.08 (-1.55%)

ULTA Ulta Beauty
$322.40 /

-5.08 (-1.55%)

ULTA Ulta Beauty
$322.40 /

-5.08 (-1.55%)

ULTA Ulta Beauty
$322.40 /

-5.08 (-1.55%)

Recommendations
Robert Half price target raised to $85 from $42 at Barclays » 07:35
03/01/21
03/01
07:35
03/01/21
07:35
RHI

Robert Half

$77.88 /

-1.53 (-1.93%)

Barclays analyst Manav…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHI Robert Half
$77.88 /

-1.53 (-1.93%)

RHI Robert Half
$77.88 /

-1.53 (-1.93%)

06:40 Today Barclays
ManpowerGroup upgraded to Overweight from Underweight at Barclays
02/03/21 BofA
Robert Half upgraded to Buy from Neutral at BofA
02/03/21
Robert Half price target raised to $67 from $52 at Truist
01/29/21 BMO Capital
Robert Half price target raised to $81 from $73 at BMO Capital
RHI Robert Half
$77.88 /

-1.53 (-1.93%)

RHI Robert Half
$77.88 /

-1.53 (-1.93%)

RHI Robert Half
$77.88 /

-1.53 (-1.93%)

Hot Stocks
Athenex trading resumes  07:35
03/01/21
03/01
07:35
03/01/21
07:35
ATNX

Athenex

$12.18 /

+0.29 (+2.44%)

 
ShowHide Related Items >><<
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Evercore ISI
Athenex initiated with an Outperform at Evercore ISI
10/26/20
Fly Intel: Top five analyst initiations
10/26/20 SVB Leerink
Athenex initiated with an Outperform at SVB Leerink
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

  • 10
    Sep
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

Hot Stocks
Mateon Therapeutics, Windlas publish PulmoHeal clinical data » 07:35
03/01/21
03/01
07:35
03/01/21
07:35
MATN

Mateon Therapeutics

$0.00 /

+ (+0.00%)

Mateon Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MATN Mateon Therapeutics
$0.00 /

+ (+0.00%)

Hot Stocks
Equinox Gold acquires additional 10% of Hardrock Project in Ontario, Canada » 07:34
03/01/21
03/01
07:34
03/01/21
07:34
EQX

Equinox Gold

$8.27 /

-0.34 (-3.95%)

Equinox Gold is pleased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQX Equinox Gold
$8.27 /

-0.34 (-3.95%)

EQX Equinox Gold
$8.27 /

-0.34 (-3.95%)

02/10/21 BMO Capital
Equinox Gold price target lowered to C$20 from C$22.50 at BMO Capital
02/09/21
Equinox Gold to hold a virtual investor reception
02/02/21 National Bank
Equinox Gold price target lowered to C$16 from C$17 at National Bank
01/12/21 BMO Capital
Equinox Gold price target raised to C$22.50 from C$22 at BMO Capital
EQX Equinox Gold
$8.27 /

-0.34 (-3.95%)

Hot Stocks
BioXcel Therapeutics appoints June Bray to board of directors » 07:34
03/01/21
03/01
07:34
03/01/21
07:34
BTAI

BioXcel Therapeutics

$53.71 /

-1.95 (-3.50%)

BioXcel Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$53.71 /

-1.95 (-3.50%)

BTAI BioXcel Therapeutics
$53.71 /

-1.95 (-3.50%)

02/01/21 UBS
BioXcel Therapeutics initiated with a Buy at UBS
01/06/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $185 from $175 at H.C. Wainwright
10/30/20
Fly Intel: Top five analyst initiations
10/30/20 Goldman Sachs
BioXcel Therapeutics initiated with a Buy at Goldman Sachs
BTAI BioXcel Therapeutics
$53.71 /

-1.95 (-3.50%)

  • 29
    Jul
BTAI BioXcel Therapeutics
$53.71 /

-1.95 (-3.50%)

Recommendations
Builders FirstSource price target raised to $52 from $48 at Truist » 07:33
03/01/21
03/01
07:33
03/01/21
07:33
BLDR

Builders FirstSource

$43.27 /

+2.72 (+6.71%)

Truist analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLDR Builders FirstSource
$43.27 /

+2.72 (+6.71%)

BLDR Builders FirstSource
$43.27 /

+2.72 (+6.71%)

07:20 Today RBC Capital
Builders FirstSource price target raised to $56 from $48 at RBC Capital
07:15 Today Barclays
Builders FirstSource price target raised to $54 from $48 at Barclays
01/13/21 BMO Capital
Builders FirstSource initiated with an Outperform at BMO Capital
01/13/21
Fly Intel: Top five analyst initiations
BLDR Builders FirstSource
$43.27 /

+2.72 (+6.71%)

BLDR Builders FirstSource
$43.27 /

+2.72 (+6.71%)

Initiation
EyePoint initiated with an Outperform at Cowen » 07:33
03/01/21
03/01
07:33
03/01/21
07:33
EYPT

EyePoint

$10.90 /

-0.08 (-0.73%)

Cowen analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYPT EyePoint
$10.90 /

-0.08 (-0.73%)

EYPT EyePoint
$10.90 /

-0.08 (-0.73%)

01/27/21 Cantor Fitzgerald
Cantor Fitzgerald starts EyePoint at Overweight with $22 price target
01/27/21 Cantor Fitzgerald
EyePoint initiated with an Overweight at Cantor Fitzgerald
01/12/21 B. Riley Securities
EyePoint price target raised to $8.50 from $5 at B. Riley Securities
01/07/21 Alliance Global Partners
Iluvien deal shows valuation disconnect at Alimera, says Alliance Global Partners
EYPT EyePoint
$10.90 /

-0.08 (-0.73%)

  • 02
    Feb
Hot Stocks
MannKind announces proposed private placement of convertible senior notes » 07:32
03/01/21
03/01
07:32
03/01/21
07:32
MNKD

MannKind

$5.72 /

+0.11 (+1.96%)

MannKind Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNKD MannKind
$5.72 /

+0.11 (+1.96%)

MNKD MannKind
$5.72 /

+0.11 (+1.96%)

02/26/21 H.C. Wainwright
MannKind price target raised to $6.50 from $2.50 at H.C. Wainwright
02/24/21 BTIG
MannKind price target raised to $8 from $4 at BTIG
12/29/20 BTIG
United Therapeutics' treprostinil development uses MannKind technology, say BTIG
MNKD MannKind
$5.72 /

+0.11 (+1.96%)

MNKD MannKind
$5.72 /

+0.11 (+1.96%)

Earnings
Biohaven Pharmaceutical reports Q4 adjusted EPS ($2.69), consensus ($2.97) » 07:32
03/01/21
03/01
07:32
03/01/21
07:32
BHVN

Biohaven Pharmaceutical

$84.92 /

+1.57 (+1.88%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$84.92 /

+1.57 (+1.88%)

BHVN Biohaven Pharmaceutical
$84.92 /

+1.57 (+1.88%)

01/25/21 Piper Sandler
Piper recommends buying Biohaven Pharmaceutical shares at current levels
01/19/21 Canaccord
Biohaven Pharmaceutical price target lowered to $101 from $110 at Canaccord
01/19/21 Mizuho
Biohaven Pharmaceutical price target lowered to $93 from $100 at Mizuho
01/19/21 H.C. Wainwright
Biohaven price target lowered to $111 from $121 at H.C. Wainwright
BHVN Biohaven Pharmaceutical
$84.92 /

+1.57 (+1.88%)

Hot Stocks
NXP Semiconductors announces expansion of EdgeVerse portfolio » 07:31
03/01/21
03/01
07:31
03/01/21
07:31
NXPI

NXP Semiconductors

$182.60 /

+3.97 (+2.22%)

NXP Semiconductors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXPI NXP Semiconductors
$182.60 /

+3.97 (+2.22%)

NXPI NXP Semiconductors
$182.60 /

+3.97 (+2.22%)

02/25/21 Citi
Citi upgrades NXP to Buy on leverage to semiconductor cycle
02/25/21 Citi
NXP Semiconductors upgraded to Buy from Neutral at Citi
02/17/21 Wells Fargo
Wells says NXP plants in Austin make up less than 30% of production sq. footage
02/03/21
Fly Intel: Top five analyst upgrades
NXPI NXP Semiconductors
$182.60 /

+3.97 (+2.22%)

NXPI NXP Semiconductors
$182.60 /

+3.97 (+2.22%)

NXPI NXP Semiconductors
$182.60 /

+3.97 (+2.22%)

NXPI NXP Semiconductors
$182.60 /

+3.97 (+2.22%)

Upgrade
Liberty Broadband upgraded to Buy from Hold at TD Securities » 07:31
03/01/21
03/01
07:31
03/01/21
07:31
LBRDK

Liberty Broadband

$149.94 /

+5.67 (+3.93%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LBRDK Liberty Broadband
$149.94 /

+5.67 (+3.93%)

LBRDK Liberty Broadband
$149.94 /

+5.67 (+3.93%)

12/16/20 Morgan Stanley
Liberty Broadband price target raised to $182 from $174 at Morgan Stanley
08/18/20 TD Securities
Liberty Broadband downgraded to Hold on valuation at TD Securities
08/17/20 Pivotal Research
GCI Liberty price target raised to $111 from $96 at Pivotal Research
LBRDK Liberty Broadband
$149.94 /

+5.67 (+3.93%)

General news
FX Update: The dollar rebounded out of lows » 07:30
03/01/21
03/01
07:30
03/01/21
07:30

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
LyondellBasell upgraded to Overweight from Neutral at Alembic Global » 07:29
03/01/21
03/01
07:29
03/01/21
07:29
LYB

LyondellBasell

$103.20 /

-1.415 (-1.35%)

Alembic Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYB LyondellBasell
$103.20 /

-1.415 (-1.35%)

LYB LyondellBasell
$103.20 /

-1.415 (-1.35%)

02/22/21 BofA
LyondellBasell upgraded to Buy from Neutral at BofA
02/22/21 BofA
LyondellBasell upgraded to Buy from Neutral at BofA
02/02/21
Fly Intel: Top five analyst upgrades
02/02/21 Argus
LyondellBasell upgraded to Buy from Hold at Argus
LYB LyondellBasell
$103.20 /

-1.415 (-1.35%)

LYB LyondellBasell
$103.20 /

-1.415 (-1.35%)

Hot Stocks
Satsuma Pharmaceuticals plans to begin STS101 Phase 3 trial in mid-2021 » 07:29
03/01/21
03/01
07:29
03/01/21
07:29
STSA

Satsuma Pharmaceuticals

$5.68 /

-0.2 (-3.40%)

Satsuma Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
$5.68 /

-0.2 (-3.40%)

STSA Satsuma Pharmaceuticals
$5.68 /

-0.2 (-3.40%)

11/11/20 Mizuho
Satsuma Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
09/21/20 H.C. Wainwright
Satsuma Pharmaceuticals price target lowered to $7 from $35 at H.C. Wainwright
09/14/20 BTIG
Satsuma setback a positive for Zosano Pharma, says BTIG
09/11/20
Fly Intel: Top five analyst downgrades
STSA Satsuma Pharmaceuticals
$5.68 /

-0.2 (-3.40%)

Upgrade
Par Pacific upgraded to Outperform from Market Perform at Cowen » 07:28
03/01/21
03/01
07:28
03/01/21
07:28
PARR

Par Pacific

$17.72 /

-0.41 (-2.26%)

Cowen analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PARR Par Pacific
$17.72 /

-0.41 (-2.26%)

PARR Par Pacific
$17.72 /

-0.41 (-2.26%)

02/22/21 JPMorgan
Par Pacific upgraded to Neutral on valuation at JPMorgan
02/22/21 JPMorgan
Par Pacific upgraded to Neutral from Underweight at JPMorgan
02/17/21 Credit Suisse
Par Pacific upgraded to Neutral from Underperform at Credit Suisse
12/15/20 Goldman Sachs
Par Pacific downgraded to Neutral from Buy at Goldman Sachs
PARR Par Pacific
$17.72 /

-0.41 (-2.26%)

PARR Par Pacific
$17.72 /

-0.41 (-2.26%)

Downgrade
Tabula Rasa HealthCare downgraded to Hold from Buy at Truist » 07:28
03/01/21
03/01
07:28
03/01/21
07:28
TRHC

Tabula Rasa HealthCare

$40.57 /

-0.57 (-1.39%)

Truist analyst Sandy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRHC Tabula Rasa HealthCare
$40.57 /

-0.57 (-1.39%)

TRHC Tabula Rasa HealthCare
$40.57 /

-0.57 (-1.39%)

06:17 Today Truist
Tabula Rasa HealthCare downgraded to Hold from Buy at Truist
02/24/21 Piper Sandler
Tabula Rasa HealthCare downgraded to Neutral from Overweight at Piper Sandler
02/24/21 Cantor Fitzgerald
Cantor downgrades Tabula Rasa HealthCare to Neutral on 'underwhelming' outlook
02/24/21 Cantor Fitzgerald
Tabula Rasa HealthCare downgraded to Neutral at Cantor Fitzgerald
TRHC Tabula Rasa HealthCare
$40.57 /

-0.57 (-1.39%)

TRHC Tabula Rasa HealthCare
$40.57 /

-0.57 (-1.39%)

Hot Stocks
Maximus acquires Federal division of Attain for $430M » 07:27
03/01/21
03/01
07:27
03/01/21
07:27
MMS

Maximus

$81.36 /

-1.71 (-2.06%)

Maximus that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MMS Maximus
$81.36 /

-1.71 (-2.06%)

MMS Maximus
$81.36 /

-1.71 (-2.06%)

07/08/20
Fly Intel: Top five analyst upgrades
07/08/20 Raymond James
Maximus upgraded to Strong Buy from Market Perform at Raymond James
07/08/20 Raymond James
Maximus upgraded to Strong Buy from Market Perform at Raymond James
06/24/20 KeyBanc
Maximus upgraded to Overweight from Sector Weight at KeyBanc
MMS Maximus
$81.36 /

-1.71 (-2.06%)

Hot Stocks
NTN Buzztime board urges shareholders to vote for proposed merger, asset sale » 07:27
03/01/21
03/01
07:27
03/01/21
07:27
NTN

NTN Buzztime

$3.67 /

-0.29 (-7.32%)

The board of directors of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTN NTN Buzztime
$3.67 /

-0.29 (-7.32%)

Hot Stocks
Morphic Holding reports interim results from Phase 1 trial of MORF-057 » 07:26
03/01/21
03/01
07:26
03/01/21
07:26
MORF

Morphic Holding

$35.94 /

+2.9 (+8.78%)

Morphic Therapeutic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MORF Morphic Holding
$35.94 /

+2.9 (+8.78%)

MORF Morphic Holding
$35.94 /

+2.9 (+8.78%)

02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
MORF Morphic Holding
$35.94 /

+2.9 (+8.78%)

Hot Stocks
Agios Pharmaceuticals submits supplemental NDA to FDA for TIBSOVO » 07:25
03/01/21
03/01
07:25
03/01/21
07:25
AGIO

Agios Pharmaceuticals

$47.59 /

-2.75 (-5.46%)

Agios Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$47.59 /

-2.75 (-5.46%)

AGIO Agios Pharmaceuticals
$47.59 /

-2.75 (-5.46%)

06:42 Today JPMorgan
JPMorgan downgrades Agios on lack of 'game-changing catalysts'
04:43 Today JPMorgan
Agios Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
02/26/21 SVB Leerink
Agios Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink
01/27/21 Barclays
Agios Pharmaceuticals price target raised to $65 from $58 at Barclays
AGIO Agios Pharmaceuticals
$47.59 /

-2.75 (-5.46%)

Recommendations
Acadia price target raised to $65 from $48 at Raymond James » 07:25
03/01/21
03/01
07:25
03/01/21
07:25
ACHC

Acadia

$55.33 /

+3.99 (+7.77%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACHC Acadia
$55.33 /

+3.99 (+7.77%)

ACHC Acadia
$55.33 /

+3.99 (+7.77%)

07:05 Today Mizuho
Acadia price target raised to $53 from $50 at Mizuho
12/31/20 Credit Suisse
Acadia price target raised to $44 from $36 at Credit Suisse
12/30/20 Jefferies
Jefferies ups Acadia price target to $60 on better than expected UK deal terms
12/18/20 Mizuho
Acadia price target raised to $50 from $35 at Mizuho
ACHC Acadia
$55.33 /

+3.99 (+7.77%)

Hot Stocks
Strata Skin Sciences appoints Robert Moccia as president, CEO » 07:24
03/01/21
03/01
07:24
03/01/21
07:24
SSKN

Strata Skin Sciences

$1.81 /

-0.04 (-2.16%)

STRATA Skin Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSKN Strata Skin Sciences
$1.81 /

-0.04 (-2.16%)

SSKN Strata Skin Sciences
$1.81 /

-0.04 (-2.16%)

11/03/20
Fly Intel: Top five analyst upgrades
11/03/20 H.C. Wainwright
Strata Skin Sciences upgraded to Buy from Neutral at H.C. Wainwright
03/17/20 H.C. Wainwright
H.C. Wainwright downgrades Strata Skin Sciences to Neutral on lack of visibility
03/17/20 H.C. Wainwright
Strata Skin Sciences downgraded to Neutral from Buy at H.C. Wainwright
SSKN Strata Skin Sciences
$1.81 /

-0.04 (-2.16%)

Hot Stocks
Dana acquires Pi Innovo LLC, terms not disclosed » 07:23
03/01/21
03/01
07:23
03/01/21
07:23
DAN

Dana

$23.84 /

+0.125 (+0.53%)

Dana announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAN Dana
$23.84 /

+0.125 (+0.53%)

DAN Dana
$23.84 /

+0.125 (+0.53%)

02/19/21 Deutsche Bank
Dana price target raised to $28 from $25 at Deutsche Bank
01/20/21 Deutsche Bank
Dana price target raised to $25 from $21 at Deutsche Bank
01/11/21 BofA
Dana downgraded to Neutral from Buy at BofA
12/17/20 Barclays
Dana downgraded to Equal Weight from Overweight at Barclays
DAN Dana
$23.84 /

+0.125 (+0.53%)

Initiation
Landos Biopharma initiated with an Outperform at Raymond James » 07:23
03/01/21
03/01
07:23
03/01/21
07:23
LABP

Landos Biopharma

$13.38 /

+0.39 (+3.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LABP Landos Biopharma
$13.38 /

+0.39 (+3.00%)

LABP Landos Biopharma
$13.38 /

+0.39 (+3.00%)

06:27 Today SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
  • 04
    Feb
LABP Landos Biopharma
$13.38 /

+0.39 (+3.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.